Gsk (GSK) Shares Outstanding (2009 - 2026)
Gsk (GSK) posted quarterly Shares Outstanding (Entity) of $89.0 for Q4 2025, down 1.11% year-over-year from $90.0 in Q4 2024, and down 1.11% quarter-over-quarter from $90.0 in Q4 2024.
Gsk (GSK) Shares Outstanding (2009 - 2026) Analysis & Trends
Gsk's Shares Outstanding (Entity) history runs 17 years deep, the most recent figure standing at $89.0 for Q4 2025.
- In Q4 2025, Shares Outstanding (Entity) fell 1.11% year-over-year to $89.0; the TTM figure through Dec 2025 stood at $89.0 (down 1.11% YoY), while the FY2025 annual figure was $89.0, down 1.11% from the prior year.
- Shares Outstanding (Entity) for Q4 2025 stood at $89.0, down from $90.0 in the prior quarter.
- The five-year high for Shares Outstanding (Entity) was $90.0 in Q4 2024, with the low at $88.0 in Q4 2021.
- The 5-year median for Shares Outstanding (Entity) is $89.0 (2023), against an average of $88.86.
- The sharpest annual moves came in 2021 and 2025: Shares Outstanding (Entity) gained 1.15% in 2021, then declined 1.11% in 2025.
- Gsk's Shares Outstanding (Entity) stood at $88.0 in 2021, then changed by 0.0% to $88.0 in 2022, then advanced by 1.14% to $89.0 in 2023, then gained by 1.12% to $90.0 in 2024, then fell by 1.11% to $89.0 in 2025.
- Business Quant data shows GSK's Shares Outstanding (Entity) at $89.0 in Q4 2025, $90.0 in Q4 2024, and $89.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 2.41 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | 1.91 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | 1.55 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | 540.00 Mn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | 2.03 Bn |
| 10 | Sanofi | 55.07 Bn | 47.69 Bn | 10.79 Bn | 1.20 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.05 Bn |
| Mar 31, 2026 | 4.05 Bn |
| Dec 31, 2025 | 4.05 Bn |
| Sep 30, 2025 | 4.08 Bn |
| Jun 30, 2025 | 4.08 Bn |
| Mar 31, 2025 | 4.08 Bn |
| Dec 31, 2024 | 4.08 Bn |
| Sep 30, 2024 | 4.07 Bn |
| Jun 30, 2024 | 4.07 Bn |
| Mar 31, 2024 | 4.07 Bn |
| Dec 31, 2023 | 4.05 Bn |
| Sep 30, 2023 | 4.04 Bn |
| Jun 30, 2023 | 4.04 Bn |
| Mar 31, 2023 | 4.04 Bn |
| Dec 31, 2022 | 4.03 Bn |
| Sep 30, 2022 | 4.00 Bn |
| Jun 30, 2022 | 4.00 Bn |
| Mar 31, 2022 | 4.00 Bn |
| Dec 31, 2021 | 4.00 Bn |
| Sep 30, 2021 | 3.98 Bn |